Briefing
Ultrasensitive Detection and Monitoring of Circulating Tumor DNA Using Structural Variants in Early-Stage Breast Cancer.
The study evaluated ctDNA detection after curative-intent therapy in early breast cancer using structural variants, noting that detection in this setting is highly prognostic of recurrence.
- Design: Evidence level 3
- Assay: Not named in the abstract
Clinical Cancer ResearchPubMed 39785866DOI 10.1158/1078-0432.CCR-24-3472